AI & IPGlobal
House IP Subcommittee Debates Generics Legislation Amid Supreme Court Hikma Ruling; Trump Supports REPAIR Act; X Seeks FTC Order Modification Citing AI Leadership
Key developments in intellectual property law include Supreme Court guidance on generic drug patent infringement, presidential backing for right-to-repair legislation, and a major…
On June 4, the House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet convened to discuss proposed legislation aimed at enhancing generic drug market access following the Supreme Court’s landmark decision in Hikma v. Amarin. Concurrently, President Donald Trump publicl…